Histamine: an unexpected defender against heart and kidney damage

Histamine: an unexpected defender against heart and kidney damage
Histamine: an unexpected defender against heart and kidney damage. Credit: University of Tsukuba

Chronic kidney disease and heart failure are critical medical problems worldwide, and are closely associated in a phenomenon known as "cardiorenal syndrome." The relationship between kidney dysfunction and heart dysfunction is complex. Many studies have attempted to understand this relationship; few have provided a clear target for treatment of the combined dysfunction, until now.

In a new study published in Proceedings of the National Academy of Sciences, a University of Tsukuba research team investigated the levels of histamine, an important factor in inflammation, in with cardiorenal damage, and found that histamine was increased in the blood of these mice, compared with normal mice.

Heart failure is a condition in which the cannot pump sufficient blood to meet the body's needs, which is often demonstrated by shortness of breath, excessive fatigue, and leg swelling. Chronic kidney disease involves gradual loss of function, frequently characterized by leg swelling, fatigue, vomiting, loss of appetite, and confusion. Despite many efforts to control these two disorders, treatments for both largely involve modifications of blood vessels to mitigate their effects, rather than curative approaches to reduce the underlying disease processes.

"Histamine is an important factor in various inflammatory processes, and its inhibition generally leads to better disease control," says Akiyoshi Fukamizu, corresponding author on the study. "We found elevated levels of histamine in a mouse model of cardiorenal syndrome, which were surprisingly protective against further damage in these mice."

In the study, mice that could not produce histamine showed worse cardiorenal damage effects, including increased heart size, altered cardiac contractility, and poor urinary filtration. Similar effects were observed when a specific histamine receptor (H3) antagonist was administered to mice with cardiorenal damage, suggesting that this receptor may serve as a useful drug target.

"We found that targeting the H3 histamine receptor with an agonist, immethridine, could markedly alleviate some components of cardiorenal damage in our mouse model," says Dr. Fukamizu. "Additionally, immethridine treatment led to protective changes in that affected multiple genes linked to inflammation in these mice."

In addition to their finding that histamine can control the severity of cardiorenal syndrome in a mouse model, the researchers showed that activation of a specific receptor could alleviate signs of cardiorenal damage in these mice, providing a new potential treatment for patients with and patients with .

Explore further

NSAID pretreatment impairs immune response in heart failure, worsens heart and kidney damage

More information: Kazuyuki Noguchi el al., "Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming," PNAS (2020). www.pnas.org/cgi/doi/10.1073/pnas.1909124117
Citation: Histamine: an unexpected defender against heart and kidney damage (2020, January 27) retrieved 23 November 2020 from https://medicalxpress.com/news/2020-01-histamine-unexpected-defender-heart-kidney.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments